Tirzepatide is a synthetic, long-acting peptide engineered to activate both the glucose-dependent insulinotropic polypeptide receptor, or GIPR, and the glucagon-like peptide-1 receptor, or GLP-1R. Researchers study it because this single molecule links two incretin signaling systems while showing distinct receptor…